David Korones
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Glioma | 7 | 2001 | 51 |
Why?
| Brain Neoplasms | 10 | 1998 | 116 |
Why?
| Neoplasm Recurrence, Local | 7 | 2000 | 118 |
Why?
| Medical Oncology | 4 | 2003 | 28 |
Why?
| Dacarbazine | 4 | 2003 | 18 |
Why?
| Brain Stem Neoplasms | 3 | 2005 | 2 |
Why?
| Palliative Care | 3 | 2007 | 65 |
Why?
| Antineoplastic Agents, Alkylating | 4 | 2002 | 30 |
Why?
| Neutropenia | 4 | 1994 | 42 |
Why?
| Glioblastoma | 5 | 1998 | 44 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2003 | 121 |
Why?
| Child | 26 | 1982 | 749 |
Why?
| Child, Preschool | 24 | 1982 | 554 |
Why?
| Physician's Role | 2 | 1999 | 92 |
Why?
| Etoposide | 5 | 2000 | 37 |
Why?
| Central Nervous System Neoplasms | 2 | 1999 | 13 |
Why?
| Humanities | 1 | 2010 | 6 |
Why?
| Fever | 2 | 1997 | 65 |
Why?
| Meditation | 1 | 2010 | 7 |
Why?
| Physician-Patient Relations | 4 | 2003 | 111 |
Why?
| Burnout, Professional | 1 | 2010 | 13 |
Why?
| Choice Behavior | 1 | 2010 | 34 |
Why?
| Neoplasms | 4 | 1996 | 239 |
Why?
| Teaching | 1 | 2010 | 89 |
Why?
| Humans | 48 | 1982 | 1856 |
Why?
| Education, Medical, Graduate | 1 | 2010 | 70 |
Why?
| Purpura, Thrombocytopenic, Idiopathic | 2 | 1996 | 11 |
Why?
| Antineoplastic Agents | 3 | 2001 | 190 |
Why?
| Adaptation, Psychological | 1 | 2010 | 110 |
Why?
| Adolescent | 21 | 1982 | 891 |
Why?
| Astrocytoma | 2 | 2006 | 26 |
Why?
| Stress, Psychological | 1 | 2010 | 117 |
Why?
| Administration, Oral | 5 | 1996 | 170 |
Why?
| Female | 29 | 1982 | 1643 |
Why?
| Antineoplastic Agents, Phytogenic | 2 | 2000 | 23 |
Why?
| Radiography, Thoracic | 1 | 2004 | 41 |
Why?
| Male | 28 | 1982 | 1553 |
Why?
| Rhabdoid Tumor | 2 | 1999 | 3 |
Why?
| Neoplasms, Second Primary | 1 | 2006 | 31 |
Why?
| Attitude to Death | 2 | 1999 | 29 |
Why?
| Survival Rate | 7 | 2000 | 250 |
Why?
| Meningeal Neoplasms | 2 | 1996 | 30 |
Why?
| Optic Nerve Neoplasms | 1 | 2003 | 2 |
Why?
| Neurofibromatosis 1 | 1 | 2003 | 7 |
Why?
| Treatment Outcome | 10 | 2000 | 661 |
Why?
| Bacteremia | 2 | 1992 | 25 |
Why?
| Combined Modality Therapy | 5 | 2002 | 219 |
Why?
| Thiotepa | 1 | 2002 | 6 |
Why?
| Infant | 15 | 1982 | 464 |
Why?
| Wilms Tumor | 1 | 2001 | 11 |
Why?
| Alanine Transaminase | 1 | 2001 | 20 |
Why?
| Liver Function Tests | 1 | 2001 | 25 |
Why?
| Aspartate Aminotransferases | 1 | 2001 | 33 |
Why?
| L-Lactate Dehydrogenase | 1 | 2001 | 59 |
Why?
| Magnetic Resonance Imaging | 6 | 1997 | 294 |
Why?
| Adult | 14 | 1989 | 1317 |
Why?
| Muscular Dystrophy, Duchenne | 1 | 2001 | 7 |
Why?
| Pneumonia | 2 | 1997 | 85 |
Why?
| Attitude of Health Personnel | 1 | 2003 | 165 |
Why?
| Kidney Neoplasms | 1 | 2001 | 75 |
Why?
| Retrospective Studies | 7 | 1999 | 653 |
Why?
| Muscle Proteins | 1 | 2001 | 56 |
Why?
| Ventriculoperitoneal Shunt | 1 | 1999 | 12 |
Why?
| Swimming | 1 | 1999 | 6 |
Why?
| Peritoneal Neoplasms | 1 | 1999 | 24 |
Why?
| Bone Marrow Transplantation | 1 | 2001 | 90 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2001 | 53 |
Why?
| Infection | 1 | 1999 | 57 |
Why?
| Catheterization, Central Venous | 1 | 1999 | 46 |
Why?
| Mass Chest X-Ray | 1 | 1997 | 2 |
Why?
| Antibodies, Antineutrophil Cytoplasmic | 1 | 1997 | 8 |
Why?
| Radiotherapy Dosage | 3 | 2002 | 55 |
Why?
| Isoenzymes | 1 | 2001 | 144 |
Why?
| Granulocytes | 1 | 1997 | 46 |
Why?
| Spinal Cord Neoplasms | 3 | 1997 | 17 |
Why?
| Radiotherapy | 2 | 2007 | 73 |
Why?
| Heart Atria | 1 | 1996 | 37 |
Why?
| Catheters, Indwelling | 1 | 1996 | 46 |
Why?
| Dexamethasone | 1 | 1996 | 109 |
Why?
| Echocardiography | 1 | 1996 | 93 |
Why?
| Glucocorticoids | 1 | 1996 | 107 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 1994 | 34 |
Why?
| Leukemia | 1 | 1996 | 70 |
Why?
| Pediatrics | 1 | 1999 | 133 |
Why?
| Thrombosis | 1 | 1996 | 105 |
Why?
| Pneumococcal Infections | 1 | 1994 | 31 |
Why?
| Middle Aged | 8 | 2000 | 1161 |
Why?
| Haemophilus influenzae | 2 | 1989 | 39 |
Why?
| Haemophilus Infections | 1 | 1992 | 30 |
Why?
| Literature | 1 | 2010 | 6 |
Why?
| Anecdotes as Topic | 1 | 2010 | 9 |
Why?
| Writing | 1 | 2010 | 14 |
Why?
| Narration | 1 | 2010 | 18 |
Why?
| Feedback | 1 | 2010 | 54 |
Why?
| Questionnaires | 2 | 1999 | 360 |
Why?
| Vincristine | 2 | 2005 | 27 |
Why?
| Aged | 6 | 2000 | 988 |
Why?
| HIV Infections | 1 | 1997 | 136 |
Why?
| Radiotherapy, Conformal | 1 | 2010 | 12 |
Why?
| Blood Volume | 1 | 2010 | 35 |
Why?
| Fellowships and Scholarships | 1 | 2010 | 34 |
Why?
| Truth Disclosure | 1 | 2010 | 21 |
Why?
| SEER Program | 1 | 2009 | 22 |
Why?
| Program Evaluation | 1 | 2010 | 115 |
Why?
| Osmotic Fragility | 1 | 1989 | 11 |
Why?
| Spherocytosis, Hereditary | 1 | 1989 | 5 |
Why?
| Disease-Free Survival | 3 | 2002 | 102 |
Why?
| Pilot Projects | 1 | 2010 | 264 |
Why?
| Curriculum | 1 | 2010 | 127 |
Why?
| Aged, 80 and over | 3 | 2009 | 599 |
Why?
| Diagnosis, Differential | 3 | 1997 | 402 |
Why?
| New York | 2 | 2004 | 422 |
Why?
| Radiosurgery | 1 | 2009 | 24 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1996 | 33 |
Why?
| Risk Factors | 3 | 1996 | 555 |
Why?
| Survival Analysis | 2 | 2006 | 205 |
Why?
| Time Factors | 2 | 1999 | 896 |
Why?
| Physicians | 1 | 2010 | 104 |
Why?
| Adenomatous Polyposis Coli | 2 | 1997 | 9 |
Why?
| Ependymoma | 2 | 1997 | 10 |
Why?
| Child Psychology | 1 | 2007 | 19 |
Why?
| Neoadjuvant Therapy | 1 | 2007 | 19 |
Why?
| Pain Management | 1 | 2007 | 32 |
Why?
| Chemotherapy, Adjuvant | 1 | 2007 | 55 |
Why?
| Neoplasms, Neuroepithelial | 1 | 2006 | 3 |
Why?
| Internship and Residency | 1 | 2010 | 175 |
Why?
| Genes, Retinoblastoma | 1 | 2006 | 8 |
Why?
| Loss of Heterozygosity | 1 | 2006 | 17 |
Why?
| Teratoma | 1 | 2006 | 23 |
Why?
| Genes, p53 | 1 | 2006 | 43 |
Why?
| Leukocyte Count | 2 | 1994 | 94 |
Why?
| Stem Cell Transplantation | 1 | 2007 | 50 |
Why?
| Skin Neoplasms | 1 | 2008 | 97 |
Why?
| Follow-Up Studies | 3 | 1994 | 553 |
Why?
| Choroid Plexus Neoplasms | 1 | 2004 | 4 |
Why?
| Sarcoma, Small Cell | 1 | 2004 | 2 |
Why?
| Abdominal Neoplasms | 1 | 2004 | 20 |
Why?
| Clinical Protocols | 1 | 2004 | 93 |
Why?
| Cryptococcosis | 1 | 2003 | 8 |
Why?
| Lung Diseases, Fungal | 1 | 2003 | 12 |
Why?
| Cryptococcus neoformans | 1 | 2003 | 7 |
Why?
| Opportunistic Infections | 1 | 2003 | 19 |
Why?
| Optic Chiasm | 1 | 2003 | 6 |
Why?
| Maximum Tolerated Dose | 1 | 2003 | 18 |
Why?
| Cerebellar Neoplasms | 2 | 1997 | 16 |
Why?
| Immunocompromised Host | 1 | 2003 | 70 |
Why?
| Visual Pathways | 1 | 2003 | 25 |
Why?
| Carcinoma | 1 | 2004 | 109 |
Why?
| Injections, Spinal | 1 | 2002 | 14 |
Why?
| Delivery of Health Care | 1 | 2004 | 102 |
Why?
| Cerebrospinal Fluid | 1 | 2002 | 23 |
Why?
| Penicillin Resistance | 1 | 2002 | 14 |
Why?
| Neurologic Examination | 1 | 2002 | 64 |
Why?
| Cohort Studies | 2 | 2001 | 332 |
Why?
| Practice Guidelines as Topic | 1 | 2004 | 174 |
Why?
| Analysis of Variance | 2 | 1997 | 339 |
Why?
| Leukapheresis | 1 | 2001 | 17 |
Why?
| Streptococcus | 1 | 2002 | 34 |
Why?
| Age Factors | 1 | 2004 | 480 |
Why?
| Creatine Kinase | 1 | 2001 | 37 |
Why?
| Medulloblastoma | 1 | 2000 | 13 |
Why?
| Remission Induction | 1 | 2001 | 64 |
Why?
| Spinal Neoplasms | 1 | 2000 | 13 |
Why?
| Population Surveillance | 1 | 2001 | 70 |
Why?
| Liver Diseases | 1 | 2001 | 56 |
Why?
| Neoplasm Staging | 1 | 2002 | 125 |
Why?
| Transplantation, Homologous | 1 | 2001 | 94 |
Why?
| Blood Transfusion | 1 | 2001 | 59 |
Why?
| Biopsy | 1 | 2001 | 207 |
Why?
| Ring Chromosomes | 1 | 1999 | 5 |
Why?
| Muscles | 1 | 2001 | 111 |
Why?
| Lymphoma, Non-Hodgkin | 1 | 2002 | 41 |
Why?
| Dose-Response Relationship, Drug | 1 | 2003 | 431 |
Why?
| Chromosomes, Human, Pair 22 | 1 | 1999 | 12 |
Why?
| Liver | 2 | 1982 | 248 |
Why?
| Kaplan-Meier Estimate | 2 | 2009 | 89 |
Why?
| Seasons | 1 | 1999 | 64 |
Why?
| Neoplasm Proteins | 1 | 2001 | 110 |
Why?
| Immunohistochemistry | 3 | 2003 | 355 |
Why?
| Agglutination | 1 | 1997 | 8 |
Why?
| Fluorescent Antibody Technique | 1 | 1997 | 164 |
Why?
| Neoplasms, Multiple Primary | 1 | 1997 | 39 |
Why?
| Statistics, Nonparametric | 1 | 1997 | 141 |
Why?
| Chi-Square Distribution | 1 | 1997 | 179 |
Why?
| Parenteral Nutrition, Total | 1 | 1996 | 24 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 1 | 1996 | 38 |
Why?
| HLA-A1 Antigen | 1 | 1994 | 2 |
Why?
| HLA-A2 Antigen | 1 | 1994 | 8 |
Why?
| Isoantigens | 1 | 1994 | 18 |
Why?
| Immunoglobulin A | 1 | 1994 | 39 |
Why?
| Immunoglobulin M | 1 | 1994 | 81 |
Why?
| Hospitalization | 1 | 1997 | 169 |
Why?
| Immunoglobulin G | 2 | 1989 | 191 |
Why?
| Sensitivity and Specificity | 1 | 1997 | 427 |
Why?
| Incidence | 2 | 2002 | 336 |
Why?
| Disease Progression | 2 | 2005 | 244 |
Why?
| Neutrophils | 1 | 1994 | 114 |
Why?
| Hemangiosarcoma | 1 | 1991 | 8 |
Why?
| Genes, myc | 1 | 1991 | 22 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 1991 | 29 |
Why?
| Hemangioma | 1 | 1991 | 19 |
Why?
| Ambulatory Care | 1 | 1992 | 106 |
Why?
| Bone Neoplasms | 2 | 2000 | 83 |
Why?
| Neuroblastoma | 1 | 1991 | 36 |
Why?
| Interferon-alpha | 1 | 1991 | 43 |
Why?
| Recurrence | 1 | 1992 | 261 |
Why?
| Prejudice | 1 | 2010 | 30 |
Why?
| Infant, Newborn | 1 | 1994 | 389 |
Why?
| Haptens | 1 | 1989 | 10 |
Why?
| Oligosaccharides | 1 | 1989 | 19 |
Why?
| Diphtheria Toxin | 1 | 1989 | 13 |
Why?
| Patient Participation | 1 | 2010 | 40 |
Why?
| Personal Autonomy | 1 | 2010 | 25 |
Why?
| Salvage Therapy | 1 | 2009 | 37 |
Why?
| Vaccines, Synthetic | 1 | 1989 | 30 |
Why?
| Bacterial Vaccines | 1 | 1989 | 27 |
Why?
| Vaccines | 1 | 1989 | 33 |
Why?
| Craniotomy | 1 | 2008 | 15 |
Why?
| Haemophilus Vaccines | 1 | 1989 | 20 |
Why?
| Scalp | 1 | 2008 | 21 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 1991 | 126 |
Why?
| Polysaccharides, Bacterial | 1 | 1989 | 33 |
Why?
| Antibodies, Bacterial | 1 | 1989 | 50 |
Why?
| Lung Neoplasms | 1 | 1991 | 159 |
Why?
| Receptor, Epidermal Growth Factor | 1 | 2006 | 54 |
Why?
| Dose Fractionation | 1 | 2005 | 25 |
Why?
| Young Adult | 1 | 2009 | 380 |
Why?
| Cyclosporine | 1 | 2005 | 45 |
Why?
| Tumor Markers, Biological | 1 | 2008 | 112 |
Why?
| Cerebral Ventricles | 1 | 2004 | 32 |
Why?
| Translocation, Genetic | 1 | 2004 | 35 |
Why?
| Histiocytoma, Benign Fibrous | 1 | 2003 | 24 |
Why?
| Neoplasm Invasiveness | 1 | 2004 | 105 |
Why?
| Spinal Cord | 1 | 2004 | 94 |
Why?
| Antifungal Agents | 1 | 2003 | 34 |
Why?
| Coenzyme A | 1 | 1982 | 3 |
Why?
| Reye Syndrome | 1 | 1982 | 5 |
Why?
| Biopsy, Needle | 1 | 2003 | 94 |
Why?
| Bone Marrow Neoplasms | 1 | 2000 | 3 |
Why?
| Severity of Illness Index | 1 | 2003 | 358 |
Why?
| Risk Assessment | 1 | 2003 | 324 |
Why?
| Tomography, X-Ray Computed | 1 | 2003 | 321 |
Why?
| Germ-Line Mutation | 1 | 1998 | 22 |
Why?
| Fibromatosis, Aggressive | 1 | 1997 | 2 |
Why?
| Disseminated Intravascular Coagulation | 1 | 1991 | 10 |
Why?
| Carbohydrate Conformation | 1 | 1989 | 8 |
Why?
| Axons | 1 | 1991 | 66 |
Why?
| Bacterial Capsules | 1 | 1989 | 16 |
Why?
| Immunization, Secondary | 1 | 1989 | 31 |
Why?
| Blotting, Western | 1 | 1991 | 275 |
Why?
| Structure-Activity Relationship | 1 | 1989 | 124 |
Why?
| Cell Division | 1 | 1991 | 273 |
Why?
| Recombinant Proteins | 1 | 1991 | 290 |
Why?
| Cell Line | 1 | 1991 | 375 |
Why?
| Acyl Coenzyme A | 1 | 1982 | 5 |
Why?
| Postmortem Changes | 1 | 1982 | 6 |
Why?
| Rats, Inbred Strains | 1 | 1982 | 170 |
Why?
| Rats | 1 | 1982 | 530 |
Why?
| Animals | 1 | 1982 | 1031 |
Why?
|
|
Korones's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
